Related Experiment Video
Updated: Apr 16, 2026

14:58
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
Published on: March 5, 2022
5.0K
Temporal SILAC-based quantitative proteomics identifies host factors involved in chikungunya virus replication
Emmely E Treffers1,2, Ali Tas1, Florine E M Scholte1
1Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, ZA, Leiden, The Netherlands.
Proteomics
|March 13, 2015
Summary
Chikungunya virus (CHIKV) infection impacts host cell proteins, including RNA polymerase II degradation. Downregulation of Rnd3, DDX56, Plk1, and UbcH10 aids CHIKV replication, offering potential therapeutic targets.
Area of Science:
- Virology
- Molecular Biology
- Proteomics
Background:
- Chikungunya virus (CHIKV) is a reemerging arthropod-borne pathogen causing severe arthritis.
- CHIKV outbreaks have affected millions globally since 2005.
- Viral replication relies on host cellular factors, presenting potential therapeutic targets.
Purpose of the Study:
- To define the temporal dynamics of the cellular proteome during CHIKV infection.
- To identify host proteins crucial for CHIKV replication.
- To explore potential therapeutic targets against CHIKV.
Main Methods:
- Stable Isotope Labeling by Amino acids in Cell culture (SILAC) coupled with Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) were employed.
- Proteomic analysis was performed on infected cells at 8, 10, and 12 hours postinfection.
- Differential protein expression analysis identified host factors affected by CHIKV.
Main Results:
- Over 4700 proteins were identified, with 2800-3500 quantified per time point.
- A significant number of proteins, including RNA polymerase II subunits, showed decreased abundance over time.
- Downregulation of Rho family GTPase 3 (Rnd3), DEAD box helicase 56 (DDX56), polo-like kinase 1 (Plk1), and ubiquitin-conjugating enzyme E2C (UbcH10) was observed.
Conclusions:
- CHIKV infection leads to host transcriptional shut-off, partly via RNA polymerase II degradation.
- Overexpression of downregulated proteins (Rnd3, DDX56, Plk1, UbcH10) reduced CHIKV susceptibility, indicating their importance for viral replication.
- These host factors represent promising targets for developing CHIKV therapeutics.

